We are live on ! Find out more
MJRIC

Mogy Joel R Investment Counsel Portfolio holdings

AUM $1.75B
1-Year Est. Return 17.81%
This Fund
S&P 500
This Quarter Est. Return
+8.24%
1 Year Est. Return
+17.81%
3 Year Est. Return
+97.31%
5 Year Est. Return
+136.49%
10 Year Est. Return
+593.66%
AUM
$580M
AUM Growth
+$28.8M
Cap. Flow
-$11.2M
Cap. Flow %
-1.93%
Top 10 Hldgs %
36.55%
Holding
127
New
3
Increased
25
Reduced
52
Closed
5

Top Sells

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$8.49M
2
TROW icon
T. Rowe Price
TROW
+$1.44M
3
SLB icon
SLB Ltd
SLB
+$940K
4
GE icon
GE Aerospace
GE
+$883K
5
AAPL icon
Apple
AAPL
+$880K

Sector Composition

Rank Sector Weight
1 Technology 22.09%
2 Communication Services 14.39%
3 Healthcare 14.28%
4 Consumer Discretionary 13.23%
5 Financials 12.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDLZ icon
51
Mondelez International
MDLZ
$78.9B
$2.62M 0.45%
60,886
+1,000
+2% +$44.3K
CVX icon
52
Chevron
CVX
$386B
$2.6M 0.45%
24,217
-6,384
-21% -$716K
ADBE icon
53
Adobe
ADBE
$105B
$2.34M 0.4%
18,000
CELG
54
DELISTED
Celgene Corp
CELG
$2.31M 0.4%
18,600
-300
-2% -$35.9K
NEE icon
55
NextEra Energy
NEE
$179B
$2.1M 0.36%
65,400
-2,000
-3% -$62.9K
VBR icon
56
Vanguard Morningstar Small-Cap Value ETF
VBR
$38B
$2.04M 0.35%
16,575
+450
+3% +$55.3K
MMM icon
57
3M
MMM
$94.4B
$2.02M 0.35%
12,612
SO icon
58
Southern Company
SO
$106B
$1.81M 0.31%
36,441
-3,400
-9% -$168K
CMCSA icon
59
Comcast
CMCSA
$91B
$1.79M 0.31%
47,684
BIIB icon
60
Biogen
BIIB
$30.1B
$1.78M 0.31%
6,500
BMY icon
61
Bristol-Myers Squibb
BMY
$130B
$1.75M 0.3%
32,097
-500
-2% -$27.4K
MDT icon
62
Medtronic
MDT
$116B
$1.69M 0.29%
21,020
-100
-0.5% -$7.81K
IJR icon
63
iShares Core S&P Small-Cap ETF
IJR
$112B
$1.66M 0.29%
24,025
+8,625
+56% +$595K
BKNG icon
64
Booking.com
BKNG
$160B
$1.64M 0.28%
23,000
+1,125
+5% +$74.2K
WFC icon
65
Wells Fargo
WFC
$264B
$1.62M 0.28%
29,059
WMT icon
66
Walmart Inc
WMT
$901B
$1.6M 0.28%
66,546
-3,900
-6% -$89.8K
TROW icon
67
T. Rowe Price
TROW
$24.3B
$1.54M 0.27%
22,600
-20,250
-47% -$1.44M
RTN
68
DELISTED
Raytheon Company
RTN
$1.54M 0.27%
10,100
CSX icon
69
CSX Corp
CSX
$92.5B
$1.49M 0.26%
96,000
NFLX icon
70
Netflix
NFLX
$311B
$1.36M 0.23%
92,110
+4,750
+5% +$66.6K
VO icon
71
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$1.25M 0.22%
35,852
+2,400
+7% +$82.5K
WEC icon
72
WEC Energy
WEC
$34.8B
$1.24M 0.21%
20,508
-4,782
-19% -$282K
KO icon
73
Coca-Cola
KO
$372B
$1.24M 0.21%
29,226
-1,008
-3% -$42K
SLB icon
74
SLB Ltd
SLB
$79.7B
$1.23M 0.21%
15,696
-11,500
-42% -$940K
MCD icon
75
McDonald's
MCD
$194B
$979K 0.17%
7,553

Similar funds

Mogy Joel R Investment Counsel's Q1 2017 Portfolio in Review

As of Q1 2017, Mogy Joel R Investment Counsel held 127 positions worth $580M, up 5.2% from $551M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Mogy Joel R Investment Counsel's Q1 2017 filing shows 3 new, 25 increased, 52 reduced and 5 closed positions. Its largest new stake was VanEck Biotech ETF: 2,175 shares worth $259K. The largest sale was Express Scripts Holding Company, an estimated $8.49M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Communication Services and Healthcare.

  • Mogy Joel R Investment Counsel's largest Q1 2017 buy was VanEck Biotech ETF: 2,175 shares worth $259K.
  • Mogy Joel R Investment Counsel added most to iShares Core S&P Mid-Cap ETF in Q1 2017, an estimated $3.44M increase.
  • Mogy Joel R Investment Counsel's biggest Q1 2017 reduction was Express Scripts Holding Company, cutting an estimated $8.49M.
  • Mogy Joel R Investment Counsel fully exited Mead Johnson Nutrition Company in Q1 2017, selling an estimated $405K.
  • Mogy Joel R Investment Counsel's ten largest holdings make up 37% of its $580M portfolio in Q1 2017.
  • Mogy Joel R Investment Counsel opened 3 new positions and closed 5 in Q1 2017.
  • Mogy Joel R Investment Counsel's portfolio value rose 5.2% quarter-over-quarter to $580M.

Based on Mogy Joel R Investment Counsel's 13F filing for Q1 2017, filed 9 May 2017.